Thus, although p53 loss in tumors often rendered them refractory to treatment, the relatively safe, FDA-approved drug, CQ, empowered normal cells to secrete Par-4 and induce apoptosis in tumor cells that lacked p53 tumor suppressor function. This evidence concerns the gene PAWR and neoplasm.